Ligand Announces 2026 Investor Day in New York City

Rhea-AI Summary

Ligand (Nasdaq: LGND) will host a 2026 Investor Day in New York City on December 8, 2026, at 10:30 a.m. Eastern time at the Harvard Club.

Presentations from senior management will cover strategy, recent investment activity, the royalty portfolio, and long-term financial outlook, with a live webcast on the Investor Relations site.

News Market Reaction – LGND

+2.04%

4 alerts

+2.04% Session close to close

$5.15B Market Cap

0.4x Rel. Volume

In the Jun 10 session, LGND gained 2.04%, reflecting a moderate positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 8, 2026 at 10:30 a.m. Eastern time at the Harvard Club.

The event will include presentations from Ligand’s senior management team highlighting the company’s strategy, recent investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand’s Investor Relations website at investor.ligand.com. A detailed agenda, including dial-in information, will be provided closer to the event.

About Ligand
Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. Ligand owns and manages one of the largest and most diversified portfolios of biopharmaceutical royalties in the industry, with economic interests in more than 100 development and commercial-stage assets. Ligand funds high-value programs in exchange for long-term economic interests, aligning capital with clinical and commercial success. Ligand’s royalty portfolio is designed to deliver consistent and predictable revenue streams across a broad range of therapeutic assets. Ligand also licenses its proprietary technologies, Captisol^® and NITRICIL™, to support drug development and formulation across its global partner network. For more information, visit www.ligand.com or follow Ligand on X and LinkedIn.

Contacts
Investors:
Melanie Herman
investors@ligand.com
(858) 550-7761

Media:
Kellie Walsh
media@ligand.com
(914) 315-6072

FAQ

When is the Ligand (LGND) 2026 Investor Day in New York City?

Ligand’s 2026 Investor Day is scheduled for December 8, 2026, at 10:30 a.m. Eastern time. According to Ligand, the event will be held at the Harvard Club in New York City and feature presentations from senior management.

Where will Ligand (LGND) host its 2026 Investor Day event?

Ligand will host its 2026 Investor Day at the Harvard Club in New York City. According to Ligand, the event begins at 10:30 a.m. Eastern time and will focus on strategy, investment activity, royalties, and long-term financial outlook.

How can investors access the Ligand (LGND) 2026 Investor Day webcast?

Investors can access a live webcast of Ligand’s 2026 Investor Day through the company’s Investor Relations website at investor.ligand.com. According to Ligand, webcast details and a more detailed agenda will be provided closer to the event date.

What topics will be discussed at the Ligand (LGND) 2026 Investor Day?

Ligand’s 2026 Investor Day will include presentations on company strategy, recent investment activity, royalty portfolio, and long-term financial outlook. According to Ligand, senior management will lead the sessions, offering investors deeper insight into these key areas.

Who will present at the Ligand (LGND) 2026 Investor Day in December 2026?

Presentations at the 2026 Investor Day will be given by Ligand’s senior management team. According to Ligand, management will highlight the company’s strategy, recent investments, royalty portfolio, and long-term financial outlook during the New York City event.